Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference Read more about Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference
Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025 Read more about Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025
Labcorp and Inspira Health Announce Strategic Agreement for Lab Operations Read more about Labcorp and Inspira Health Announce Strategic Agreement for Lab Operations
Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians Read more about Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians
Julia Wang Julia Wang Executive Vice President and Chief Financial Officer Julia Wang has served as Executive Vice President and Chief Financial Officer of Labcorp since December 2024.Prior to joining Labcorp, Julia served as CFO of BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235) since 2021, which she joined in 2020 as Senior Vice President, Enterprise Optimization and Deputy CFO. While at BeiGene, she was instrumental in driving business transformations through accelerating growth, nurturing innovation and cultivating a culture of sustainable operating efficiencies.Julia served as Senior Vice President, Global Business Finance and Corporate Planning at Alexion Pharmaceuticals prior to BeiGene. Before Alexion, she held leadership positions at Quest Diagnostics (NYSE: DGX), including Vice President of Finance, U.S. Regional Business and Enterprise Commercial, and Vice President of Finance, Value Creation. Julia held senior leadership roles at Johnson & Johnson (NYSE: JNJ) as CFO of various operating businesses in medical device and pharmaceuticals earlier in her career. Previously, she led finance initiatives at PepsiCo.Julia earned her MBA from Fuqua School of Business at Duke University and her BA in British Language and Literature from Shandong Normal University.
